nodes	percent_of_prediction	percent_of_DWPC	metapath
Yohimbine—ADRA1B—vas deferens—urinary bladder cancer	0.417	0.418	CbGeAlD
Yohimbine—HTR2A—urine—urinary bladder cancer	0.0377	0.0377	CbGeAlD
Yohimbine—ADRA1D—prostate gland—urinary bladder cancer	0.0364	0.0365	CbGeAlD
Yohimbine—CYP3A4—urine—urinary bladder cancer	0.0349	0.0349	CbGeAlD
Yohimbine—CYP2D6—urine—urinary bladder cancer	0.0343	0.0344	CbGeAlD
Yohimbine—ADRA1D—epithelium—urinary bladder cancer	0.0268	0.0268	CbGeAlD
Yohimbine—ADRA1B—renal system—urinary bladder cancer	0.0254	0.0254	CbGeAlD
Yohimbine—ADRA1D—urethra—urinary bladder cancer	0.0244	0.0244	CbGeAlD
Yohimbine—ADRA2C—prostate gland—urinary bladder cancer	0.0199	0.02	CbGeAlD
Yohimbine—ADRA1D—female reproductive system—urinary bladder cancer	0.0199	0.0199	CbGeAlD
Yohimbine—HTR2B—smooth muscle tissue—urinary bladder cancer	0.0179	0.018	CbGeAlD
Yohimbine—ADRA2C—seminal vesicle—urinary bladder cancer	0.0169	0.0169	CbGeAlD
Yohimbine—ADRA2A—prostate gland—urinary bladder cancer	0.0159	0.0159	CbGeAlD
Yohimbine—HTR1A—renal system—urinary bladder cancer	0.0155	0.0155	CbGeAlD
Yohimbine—HTR1B—female reproductive system—urinary bladder cancer	0.0154	0.0154	CbGeAlD
Yohimbine—HTR1D—female reproductive system—urinary bladder cancer	0.0149	0.0149	CbGeAlD
Yohimbine—HTR2C—female reproductive system—urinary bladder cancer	0.0147	0.0147	CbGeAlD
Yohimbine—SLC6A4—female reproductive system—urinary bladder cancer	0.014	0.014	CbGeAlD
Yohimbine—HTR2B—female reproductive system—urinary bladder cancer	0.0138	0.0139	CbGeAlD
Yohimbine—ADRA2C—renal system—urinary bladder cancer	0.0136	0.0136	CbGeAlD
Yohimbine—ADRA2A—seminal vesicle—urinary bladder cancer	0.0135	0.0135	CbGeAlD
Yohimbine—ADRA2C—urethra—urinary bladder cancer	0.0134	0.0134	CbGeAlD
Yohimbine—HTR2B—vagina—urinary bladder cancer	0.0125	0.0125	CbGeAlD
Yohimbine—ADRA2A—urethra—urinary bladder cancer	0.0107	0.0107	CbGeAlD
Yohimbine—HTR2A—epithelium—urinary bladder cancer	0.00994	0.00996	CbGeAlD
Yohimbine—ADRA2C—vagina—urinary bladder cancer	0.00984	0.00986	CbGeAlD
Yohimbine—HTR2A—smooth muscle tissue—urinary bladder cancer	0.00958	0.00959	CbGeAlD
Yohimbine—HTR2A—renal system—urinary bladder cancer	0.00922	0.00924	CbGeAlD
Yohimbine—ADRA2A—female reproductive system—urinary bladder cancer	0.00869	0.0087	CbGeAlD
Yohimbine—CYP3A4—renal system—urinary bladder cancer	0.00854	0.00855	CbGeAlD
Yohimbine—CYP2D6—renal system—urinary bladder cancer	0.0084	0.00841	CbGeAlD
Yohimbine—HTR2B—lymph node—urinary bladder cancer	0.00809	0.0081	CbGeAlD
Yohimbine—ADRA2A—vagina—urinary bladder cancer	0.00785	0.00787	CbGeAlD
Yohimbine—HTR2A—female reproductive system—urinary bladder cancer	0.00738	0.0074	CbGeAlD
Yohimbine—CYP3A4—female reproductive system—urinary bladder cancer	0.00684	0.00685	CbGeAlD
Yohimbine—CYP2D6—female reproductive system—urinary bladder cancer	0.00673	0.00674	CbGeAlD
Yohimbine—HTR2A—vagina—urinary bladder cancer	0.00668	0.00669	CbGeAlD
Yohimbine—ADRA2C—lymph node—urinary bladder cancer	0.00637	0.00638	CbGeAlD
Yohimbine—ADRA2A—lymph node—urinary bladder cancer	0.00508	0.00509	CbGeAlD
Yohimbine—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	4.12e-07	0.000263	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—CREBBP—urinary bladder cancer	4.12e-07	0.000263	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—MMP9—urinary bladder cancer	4.1e-07	0.000262	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling by GPCR—KRAS—urinary bladder cancer	4.09e-07	0.000261	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—ERBB2—urinary bladder cancer	4.09e-07	0.000261	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—ERBB2—urinary bladder cancer	4.09e-07	0.000261	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—CDKN1A—urinary bladder cancer	4.08e-07	0.000261	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—PTEN—urinary bladder cancer	4.08e-07	0.00026	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—IGF1—urinary bladder cancer	4.07e-07	0.00026	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—CREBBP—urinary bladder cancer	4.05e-07	0.000259	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling by GPCR—EGFR—urinary bladder cancer	4.05e-07	0.000259	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—PTGS2—urinary bladder cancer	4.03e-07	0.000258	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—MMP9—urinary bladder cancer	4.01e-07	0.000256	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	4.01e-07	0.000256	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	4.01e-07	0.000256	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—IGF1—urinary bladder cancer	4e-07	0.000256	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—CREBBP—urinary bladder cancer	4e-07	0.000256	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—CDKN1A—urinary bladder cancer	4e-07	0.000256	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—PTEN—urinary bladder cancer	3.99e-07	0.000255	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—RHOA—urinary bladder cancer	3.99e-07	0.000255	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—IL2—urinary bladder cancer	3.98e-07	0.000255	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling by GPCR—EGFR—urinary bladder cancer	3.98e-07	0.000254	CbGpPWpGaD
Yohimbine—HTR1A—Signaling by GPCR—KRAS—urinary bladder cancer	3.95e-07	0.000252	CbGpPWpGaD
Yohimbine—HTR2C—Signaling by GPCR—KRAS—urinary bladder cancer	3.93e-07	0.000251	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—FGFR3—urinary bladder cancer	3.93e-07	0.000251	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	3.89e-07	0.000248	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—EP300—urinary bladder cancer	3.89e-07	0.000248	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—CCND1—urinary bladder cancer	3.88e-07	0.000248	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—CXCL8—urinary bladder cancer	3.88e-07	0.000248	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—CXCL8—urinary bladder cancer	3.88e-07	0.000248	CbGpPWpGaD
Yohimbine—DRD3—Signaling by GPCR—HRAS—urinary bladder cancer	3.85e-07	0.000246	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling by GPCR—HRAS—urinary bladder cancer	3.85e-07	0.000246	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—RHOA—urinary bladder cancer	3.85e-07	0.000246	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—TYMS—urinary bladder cancer	3.83e-07	0.000245	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—RHOA—urinary bladder cancer	3.83e-07	0.000245	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling by GPCR—KRAS—urinary bladder cancer	3.82e-07	0.000244	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—ESR1—urinary bladder cancer	3.82e-07	0.000244	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—EP300—urinary bladder cancer	3.81e-07	0.000243	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	3.79e-07	0.000242	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	3.79e-07	0.000242	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—SRC—urinary bladder cancer	3.78e-07	0.000241	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—MMP9—urinary bladder cancer	3.77e-07	0.000241	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling by GPCR—KRAS—urinary bladder cancer	3.76e-07	0.00024	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—CDKN1A—urinary bladder cancer	3.76e-07	0.00024	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—PTEN—urinary bladder cancer	3.75e-07	0.000239	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—CREBBP—urinary bladder cancer	3.74e-07	0.000239	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—RHOA—urinary bladder cancer	3.73e-07	0.000238	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—IL2—urinary bladder cancer	3.71e-07	0.000237	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—IL2—urinary bladder cancer	3.71e-07	0.000237	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—SRC—urinary bladder cancer	3.7e-07	0.000236	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—ERBB2—urinary bladder cancer	3.69e-07	0.000236	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—IGF1—urinary bladder cancer	3.69e-07	0.000236	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—CREBBP—urinary bladder cancer	3.68e-07	0.000235	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—EGFR—urinary bladder cancer	3.67e-07	0.000235	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—RHOA—urinary bladder cancer	3.67e-07	0.000234	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—IGF1—urinary bladder cancer	3.63e-07	0.000232	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—GPX1—urinary bladder cancer	3.63e-07	0.000232	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—CCND1—urinary bladder cancer	3.61e-07	0.000231	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—CCND1—urinary bladder cancer	3.61e-07	0.000231	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—EGFR—urinary bladder cancer	3.61e-07	0.000231	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—EP300—urinary bladder cancer	3.57e-07	0.000228	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—ERBB2—urinary bladder cancer	3.56e-07	0.000228	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	3.56e-07	0.000227	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—ERBB2—urinary bladder cancer	3.55e-07	0.000227	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—PTEN—urinary bladder cancer	3.52e-07	0.000225	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—MMP9—urinary bladder cancer	3.51e-07	0.000224	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—MMP9—urinary bladder cancer	3.51e-07	0.000224	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—CXCL8—urinary bladder cancer	3.5e-07	0.000224	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—CDKN1A—urinary bladder cancer	3.5e-07	0.000223	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—CDKN1A—urinary bladder cancer	3.5e-07	0.000223	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—PTEN—urinary bladder cancer	3.49e-07	0.000223	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—PTEN—urinary bladder cancer	3.49e-07	0.000223	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling by GPCR—HRAS—urinary bladder cancer	3.48e-07	0.000222	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—SRC—urinary bladder cancer	3.48e-07	0.000222	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—KRAS—urinary bladder cancer	3.47e-07	0.000222	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—ERBB2—urinary bladder cancer	3.45e-07	0.00022	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—KRAS—urinary bladder cancer	3.41e-07	0.000218	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—ERBB2—urinary bladder cancer	3.39e-07	0.000217	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—MYC—urinary bladder cancer	3.39e-07	0.000216	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—RHOA—urinary bladder cancer	3.38e-07	0.000216	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—CXCL8—urinary bladder cancer	3.38e-07	0.000216	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—CXCL8—urinary bladder cancer	3.36e-07	0.000215	CbGpPWpGaD
Yohimbine—HTR1A—Signaling by GPCR—HRAS—urinary bladder cancer	3.36e-07	0.000215	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—EP300—urinary bladder cancer	3.35e-07	0.000214	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	3.35e-07	0.000214	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—IL2—urinary bladder cancer	3.35e-07	0.000214	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—CREBBP—urinary bladder cancer	3.35e-07	0.000214	CbGpPWpGaD
Yohimbine—HTR2C—Signaling by GPCR—HRAS—urinary bladder cancer	3.34e-07	0.000213	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—RHOA—urinary bladder cancer	3.33e-07	0.000213	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—EP300—urinary bladder cancer	3.33e-07	0.000213	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—EP300—urinary bladder cancer	3.33e-07	0.000213	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—MYC—urinary bladder cancer	3.32e-07	0.000212	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—EGFR—urinary bladder cancer	3.31e-07	0.000212	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—IGF1—urinary bladder cancer	3.3e-07	0.000211	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—EGFR—urinary bladder cancer	3.29e-07	0.00021	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—PTGS2—urinary bladder cancer	3.28e-07	0.000209	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—CXCL8—urinary bladder cancer	3.27e-07	0.000209	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—CCND1—urinary bladder cancer	3.26e-07	0.000208	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling by GPCR—HRAS—urinary bladder cancer	3.25e-07	0.000208	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—EGFR—urinary bladder cancer	3.24e-07	0.000207	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—SRC—urinary bladder cancer	3.23e-07	0.000207	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—SRC—urinary bladder cancer	3.23e-07	0.000207	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—IL2—urinary bladder cancer	3.23e-07	0.000206	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	3.23e-07	0.000206	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—CXCL8—urinary bladder cancer	3.22e-07	0.000206	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—IL2—urinary bladder cancer	3.21e-07	0.000205	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling by GPCR—HRAS—urinary bladder cancer	3.2e-07	0.000204	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—MMP9—urinary bladder cancer	3.17e-07	0.000202	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—CDKN1A—urinary bladder cancer	3.16e-07	0.000202	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—CCND1—urinary bladder cancer	3.15e-07	0.000201	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—PTEN—urinary bladder cancer	3.15e-07	0.000201	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—CCND1—urinary bladder cancer	3.13e-07	0.0002	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—ERBB2—urinary bladder cancer	3.13e-07	0.0002	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—KRAS—urinary bladder cancer	3.13e-07	0.0002	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—IL2—urinary bladder cancer	3.13e-07	0.0002	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—MYC—urinary bladder cancer	3.12e-07	0.000199	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—KRAS—urinary bladder cancer	3.11e-07	0.000198	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—ERBB2—urinary bladder cancer	3.08e-07	0.000197	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—IL2—urinary bladder cancer	3.08e-07	0.000197	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—KRAS—urinary bladder cancer	3.06e-07	0.000196	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—MMP9—urinary bladder cancer	3.06e-07	0.000195	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—CCND1—urinary bladder cancer	3.05e-07	0.000195	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—EGFR—urinary bladder cancer	3.05e-07	0.000195	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—CDKN1A—urinary bladder cancer	3.05e-07	0.000195	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—MMP9—urinary bladder cancer	3.04e-07	0.000194	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—PTEN—urinary bladder cancer	3.04e-07	0.000194	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—CDKN1A—urinary bladder cancer	3.03e-07	0.000194	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—RHOA—urinary bladder cancer	3.03e-07	0.000193	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—PTEN—urinary bladder cancer	3.02e-07	0.000193	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—EP300—urinary bladder cancer	3e-07	0.000192	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—CCND1—urinary bladder cancer	3e-07	0.000192	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—CXCL8—urinary bladder cancer	2.97e-07	0.00019	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—MMP9—urinary bladder cancer	2.96e-07	0.000189	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—HRAS—urinary bladder cancer	2.95e-07	0.000188	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—CDKN1A—urinary bladder cancer	2.95e-07	0.000188	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—PTEN—urinary bladder cancer	2.94e-07	0.000188	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—CXCL8—urinary bladder cancer	2.92e-07	0.000187	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—SRC—urinary bladder cancer	2.92e-07	0.000187	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—MMP9—urinary bladder cancer	2.91e-07	0.000186	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—HRAS—urinary bladder cancer	2.9e-07	0.000185	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—CDKN1A—urinary bladder cancer	2.9e-07	0.000185	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—EP300—urinary bladder cancer	2.9e-07	0.000185	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—MYC—urinary bladder cancer	2.9e-07	0.000185	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—MYC—urinary bladder cancer	2.9e-07	0.000185	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—PTEN—urinary bladder cancer	2.89e-07	0.000185	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—EP300—urinary bladder cancer	2.88e-07	0.000184	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—KRAS—urinary bladder cancer	2.88e-07	0.000184	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—PTEN—urinary bladder cancer	2.86e-07	0.000183	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—IL2—urinary bladder cancer	2.84e-07	0.000181	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—EGFR—urinary bladder cancer	2.83e-07	0.000181	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—EGFR—urinary bladder cancer	2.83e-07	0.000181	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—SRC—urinary bladder cancer	2.82e-07	0.00018	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—EP300—urinary bladder cancer	2.81e-07	0.000179	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—SRC—urinary bladder cancer	2.8e-07	0.000179	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—ERBB2—urinary bladder cancer	2.8e-07	0.000179	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—IL2—urinary bladder cancer	2.79e-07	0.000178	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—TP53—urinary bladder cancer	2.78e-07	0.000178	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—CCND1—urinary bladder cancer	2.77e-07	0.000177	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—EP300—urinary bladder cancer	2.76e-07	0.000176	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—SRC—urinary bladder cancer	2.73e-07	0.000174	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—EP300—urinary bladder cancer	2.72e-07	0.000174	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—TP53—urinary bladder cancer	2.72e-07	0.000174	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—CCND1—urinary bladder cancer	2.72e-07	0.000174	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	2.71e-07	0.000173	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	2.69e-07	0.000172	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—SRC—urinary bladder cancer	2.68e-07	0.000172	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—MMP9—urinary bladder cancer	2.68e-07	0.000172	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—KRAS—urinary bladder cancer	2.68e-07	0.000171	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—KRAS—urinary bladder cancer	2.68e-07	0.000171	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—CDKN1A—urinary bladder cancer	2.67e-07	0.000171	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—PTEN—urinary bladder cancer	2.67e-07	0.000171	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—HRAS—urinary bladder cancer	2.66e-07	0.00017	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—CXCL8—urinary bladder cancer	2.66e-07	0.00017	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—MMP9—urinary bladder cancer	2.64e-07	0.000169	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—HRAS—urinary bladder cancer	2.64e-07	0.000169	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—CDKN1A—urinary bladder cancer	2.63e-07	0.000168	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—PTEN—urinary bladder cancer	2.63e-07	0.000168	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—MYC—urinary bladder cancer	2.62e-07	0.000167	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	2.61e-07	0.000167	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—HRAS—urinary bladder cancer	2.6e-07	0.000166	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—EGFR—urinary bladder cancer	2.56e-07	0.000164	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—TP53—urinary bladder cancer	2.56e-07	0.000163	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—EP300—urinary bladder cancer	2.55e-07	0.000163	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—IL2—urinary bladder cancer	2.54e-07	0.000162	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—MYC—urinary bladder cancer	2.53e-07	0.000161	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—MYC—urinary bladder cancer	2.51e-07	0.000161	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	2.5e-07	0.00016	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—EP300—urinary bladder cancer	2.5e-07	0.00016	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	2.48e-07	0.000158	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	2.48e-07	0.000158	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—CCND1—urinary bladder cancer	2.48e-07	0.000158	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—SRC—urinary bladder cancer	2.48e-07	0.000158	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—EGFR—urinary bladder cancer	2.47e-07	0.000158	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—EGFR—urinary bladder cancer	2.46e-07	0.000157	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—HRAS—urinary bladder cancer	2.45e-07	0.000156	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—MYC—urinary bladder cancer	2.44e-07	0.000156	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—SRC—urinary bladder cancer	2.44e-07	0.000156	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—KRAS—urinary bladder cancer	2.42e-07	0.000154	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—MYC—urinary bladder cancer	2.41e-07	0.000154	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—MMP9—urinary bladder cancer	2.4e-07	0.000154	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—CDKN1A—urinary bladder cancer	2.39e-07	0.000153	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—EGFR—urinary bladder cancer	2.39e-07	0.000153	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—PTEN—urinary bladder cancer	2.39e-07	0.000153	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—TP53—urinary bladder cancer	2.38e-07	0.000152	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—TP53—urinary bladder cancer	2.38e-07	0.000152	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	2.37e-07	0.000151	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—EGFR—urinary bladder cancer	2.35e-07	0.00015	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—KRAS—urinary bladder cancer	2.33e-07	0.000149	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	2.33e-07	0.000149	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—KRAS—urinary bladder cancer	2.32e-07	0.000148	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—EP300—urinary bladder cancer	2.28e-07	0.000146	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—HRAS—urinary bladder cancer	2.28e-07	0.000145	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—HRAS—urinary bladder cancer	2.28e-07	0.000145	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—KRAS—urinary bladder cancer	2.26e-07	0.000144	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—KRAS—urinary bladder cancer	2.22e-07	0.000142	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—MYC—urinary bladder cancer	2.22e-07	0.000142	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—SRC—urinary bladder cancer	2.22e-07	0.000142	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	2.19e-07	0.00014	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—MYC—urinary bladder cancer	2.18e-07	0.000139	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—EGFR—urinary bladder cancer	2.17e-07	0.000139	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—TP53—urinary bladder cancer	2.15e-07	0.000137	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	2.13e-07	0.000136	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—EGFR—urinary bladder cancer	2.13e-07	0.000136	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—TP53—urinary bladder cancer	2.07e-07	0.000133	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—TP53—urinary bladder cancer	2.06e-07	0.000132	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—HRAS—urinary bladder cancer	2.06e-07	0.000131	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—KRAS—urinary bladder cancer	2.05e-07	0.000131	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—KRAS—urinary bladder cancer	2.02e-07	0.000129	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—TP53—urinary bladder cancer	2.01e-07	0.000128	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—MYC—urinary bladder cancer	1.99e-07	0.000127	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—HRAS—urinary bladder cancer	1.98e-07	0.000127	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—TP53—urinary bladder cancer	1.98e-07	0.000126	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—HRAS—urinary bladder cancer	1.97e-07	0.000126	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—EGFR—urinary bladder cancer	1.94e-07	0.000124	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—HRAS—urinary bladder cancer	1.92e-07	0.000123	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—HRAS—urinary bladder cancer	1.89e-07	0.000121	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	1.86e-07	0.000119	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—KRAS—urinary bladder cancer	1.83e-07	0.000117	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—TP53—urinary bladder cancer	1.82e-07	0.000116	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—TP53—urinary bladder cancer	1.79e-07	0.000114	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—EP300—urinary bladder cancer	1.78e-07	0.000113	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.77e-07	0.000113	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—HRAS—urinary bladder cancer	1.74e-07	0.000111	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—HRAS—urinary bladder cancer	1.71e-07	0.00011	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.7e-07	0.000109	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—TP53—urinary bladder cancer	1.63e-07	0.000104	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—HRAS—urinary bladder cancer	1.56e-07	9.96e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	1.4e-07	8.92e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	1.22e-07	7.78e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—EP300—urinary bladder cancer	1.16e-07	7.42e-05	CbGpPWpGaD
